The Food and Drug Administration's Veterinary Medicine Advisory Committee on Monday considered whether to endorse AquaBounty Technologies' bioengineered salmon as safe for human consumption, but instead of voting, the panel called for further research to demonstrate the fish's safety. Some panelists argued that more data is needed about potential allergens and health risks linked to the fish.

Related Summaries